Cross-border IP Position JTG as a bridge for trans-Pacific technology transfer between Japan and North America, highlighting opportunities to license Japanese innovations to US pharma and tech firms, and to source Western innovations for Japanese collaborators.

Mid-market focus Target small to mid-sized enterprises with limited in-house M&A or licensing capacity; emphasize JTG’s specialization in identifying untapped innovations within universities and research centers to fill a strategic gap for growth-minded clients.

University networks Leverage JTG’s university and spin-off connections to unlock early access to cutting-edge Japanese research and Western-adapted innovations, offering firms a pipeline for differentiated IP opportunities.

Tech-stack leverage Utilize existing analytics and web tools (Google Analytics, Tag Manager, RequireJS, jQuery, etc.) to optimize target account profiling, measure outreach effectiveness, and tailor outreach to biotech, pharma, and tech transfer stakeholders.

Growth signals With revenue in the low-to-mid single digits and a lean team, position JTG as a cost-effective partner for strategic IP scouting, licensing deals, and cross-border partnerships that can scale with the right channel partners and intermediaries.